SCHEMBL430601

SCHEMBL430601

CC(=O)c1ccc2c(c1C(C)=O)C(=O)c1ccccc1C2=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.53
ALDH1A1 P00352 8/20 0.53
MAPK1 P28482 6/20 0.53
MEN1 O00255 6/20 0.53
KMT2A Q03164 6/20 0.53
LMNA P02545 3/20 0.53
RECQL P46063 2/20 0.53
POLB P06746 2/20 0.53
THRB P10828 1/20 0.53
SMN1; SMN2 Q16637 6/20 0.53
MITF O75030 2/20 0.53
KDM4E B2RXH2 2/20 0.53
MMP14 P50281 1/20 0.53
L3MBTL1 Q9Y468 3/20 0.50
HTT P42858 2/20 0.50
PKM P14618 1/20 0.49
MAOA P21397 2/20 0.49
ELANE P08246 1/20 0.49
CYP3A4 P08684 3/20 0.47
BCL2 P10415 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28226729 0.81 MAOA (0.59) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL8744278 0.81 MAPT (0.73) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL11147739 0.80 ALDH1A1 (0.70) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL15699972 0.79 PKLR (0.54) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL21177305 0.79 SMN1; SMN2 (0.62) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL10438300 0.79 MAPT (0.78) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL68628 0.77 MAPT (0.68) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL2605003 0.77 KEAP1 (0.68) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL10500642 0.76 KEAP1 (0.62) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL68969 0.76 MAPT (0.73) MAPTALDH1A1MAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103025340-B Aloe vera composition and its use in preparing medicaments for anti-viral and treating Acquired Immune Deficiency Syndrome (AIDS) NORTH TEXAS MEDICAL ASS 2014-12-24 CN claimed
EP-2595643-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT North Texas Medical Associates (US) 2013-05-29 EP claimed
CN-103025340-A Antiviral properties of Aloe vera and treatment of Acquired Immune Deficiency Syndrome (AIDS) NORTH TEXAS MEDICAL ASS 2013-04-03 CN claimed
US-20120022018-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT NORTH TEXAS MEDICAL ASSOCIATES (US) 2012-01-26 US claimed
WO-2012012513-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT NORTH TEXAS MEDICAL ASSOCIATES (US) 2012-01-26 WO claimed
EP-0002321-B1 PHOTOPOLYMERISABLE ELEMENTS AND A PROCESS FOR THE PRODUCTION OF PRINTING PLATES THEREFROM BEXFORD LIMITED (GB) 1981-10-28 EP claimed
US-4289843-A AROMATIC OXOAMINE INITIATOR BEXFORD LIMITED (GB) 1981-09-15 US claimed
EP-0002321-A2 Photopolymerisable elements and a process for the production of printing plates therefrom BEXFORD LIMITED (GB) 1979-06-13 EP claimed
CN-103025340-B Aloe vera composition and its use in preparing medicaments for anti-viral and treating Acquired Immune Deficiency Syndrome (AIDS) NORTH TEXAS MEDICAL ASS 2014-12-24 CN disclosed
EP-2595643-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT North Texas Medical Associates (US) 2013-05-29 EP disclosed
CN-103025340-A Antiviral properties of Aloe vera and treatment of Acquired Immune Deficiency Syndrome (AIDS) NORTH TEXAS MEDICAL ASS 2013-04-03 CN disclosed
US-20120022018-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT NORTH TEXAS MEDICAL ASSOCIATES (US) 2012-01-26 US disclosed
WO-2012012513-A1 ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT NORTH TEXAS MEDICAL ASSOCIATES (US) 2012-01-26 WO disclosed
US-6624192-B1 Diacetylrhein containing aloe-emodin components is subjected to a liquid-liquid partitioning between a polar organic solvent which is only partly miscible with water and an aqueous phase of pH 6.5 to 7.5 and the diacetylrhein is MADAUS AG (DE) 2003-09-23 US disclosed
EP-0017336-B1 PHOTOPOLYMERISABLE ELEMENTS, AND RELIEF PRINTING PLATES MADE THEREFROM BEXFORD LIMITED (GB) 1983-10-12 EP disclosed
US-4315066-A ADHESIVES OF AN UNSATURATED POLYESTER OF MALEIC ACID AND AN ALKOXYLATED BISPHENOL A; PHOTORESISTS BEXFORD LIMITED (GB) 1982-02-09 US disclosed
EP-0002321-B1 PHOTOPOLYMERISABLE ELEMENTS AND A PROCESS FOR THE PRODUCTION OF PRINTING PLATES THEREFROM BEXFORD LIMITED (GB) 1981-10-28 EP disclosed
US-4289843-A AROMATIC OXOAMINE INITIATOR BEXFORD LIMITED (GB) 1981-09-15 US disclosed
EP-0017336-A1 Photopolymerisable elements, and relief printing plates made therefrom BEXFORD LIMITED (GB) 1980-10-15 EP disclosed
EP-0002321-A2 Photopolymerisable elements and a process for the production of printing plates therefrom BEXFORD LIMITED (GB) 1979-06-13 EP disclosed